발행물

전체 논문

81

31

Effects of CYP2C19 haplotype on the pharmacokinetics and pharmacodynamics of omeprazole
배정우
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009

32

Effects of ursodeoxycholic acid, hepatic nuclear factor 1a inhibitor, on the pharmacokinetics of OATP1B1 substrate pitavastatin
배정우
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009

33

HPLC Analysis of Plasma Glipizide and its Application to Pharmacokinetic Study
Bae, JW, Kim, NT, Choi, CI, Kim, MJ, Jang, CG, Lee, SY
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2009

34

Effects of CYP2D6 polymorphism on the pharmacodynamics of metoprolol in healthy Korean subjects
배정우
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008

35

CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of glipizide in healthy Korean subjects
배정우
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008

36

Effects of CYP2C9 and CYP2C19 polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy Korean subjects
배정우
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008

37

Effects of CYP2C19, CYP2D6 and CYP3A5 polymorphisms on the pharmacokinetics of cilostazol in healthy Korean subjects
배정우
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008

38

Analytical HPLC method validation of amiloride and its pharmacokinetic study in humans
Myung C.-S., Bae J.-W., Kim M.-J., Choi C.-I., Song Y., Sa J.-H., Jang C.-G., Lee S.-Y., Park Y.-S.
Journal of Liquid Chromatography and Related Technologies, 2008

39

Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study
Bae, JW, Kim, MJ, Jang, CG, Lee, SY
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007

40

Effects of CYP2C9 polymorphism on the pharmacokinetics and pharmacodynamics of meloxicam in healthy Korean subjects
배정우
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007